Adverse Events in Radiation/Biologic Combination Therapy for Older Non-Small-Cell Lung Cancer Patients

被引：0
|
作者：
Yerigeri, K. B. [1 ]
Zhang, J. [2 ]
Marrone, K. [2 ]
机构：
[1] Northeast Ohio Med Univ, Rootstown, OH USA
[2] Johns Hopkins, Sidney Kimmel Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2019年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
D37
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [31] What radiation dose is safe in patients with non-small-cell lung cancer?
    Nicole A Larrier
    Lawrence B Marks
    Nature Clinical Practice Oncology, 2007, 4 : 80 - 81
  • [32] EFFECT OF GENETIC POLYMORPHISMS ON ERLOTINIB PHARMACOKINETICS AND ADVERSE EVENTS JAPANESE PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC).
    Hamada, A.
    Sasaki, J.
    Saeki, S.
    Inaba, M.
    Ushijima, S.
    Kishi, H.
    Fujii, S.
    Semba, H.
    Kashiwabara, K.
    Tsubata, Y.
    Tsukude, C. E.
    Shimizu, Y. K.
    Isobe, T.
    Kohrog, H.
    Saito, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S25 - S25
  • [33] Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
    Yoshida, Tsukasa
    Yamada, Kazuhiko
    Azuma, Koichi
    Kawahara, Akihiko
    Abe, Hideyuki
    Hattori, Satoshi
    Yamashita, Fumie
    Zaizen, Yoshiaki
    Kage, Masayoshi
    Hoshino, Tomoaki
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [34] Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
    Tsukasa Yoshida
    Kazuhiko Yamada
    Koichi Azuma
    Akihiko Kawahara
    Hideyuki Abe
    Satoshi Hattori
    Fumie Yamashita
    Yoshiaki Zaizen
    Masayoshi Kage
    Tomoaki Hoshino
    Medical Oncology, 2013, 30
  • [35] In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non-small-cell Lung Cancer
    Schoenmaekers, Janna
    Dijkstra, Jeanet
    van der Wekken, Anthonie
    Paats, Marthe
    Broen, Martijn
    Brandts, Lloyd
    Dingemans, Anne-Marie
    Hendriks, Lizza
    CLINICAL LUNG CANCER, 2024, 25 (02) : 168 - 174.e1
  • [36] Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer
    Chang, Bee -song
    Peng, Tai-chu
    Lue, Kun-han
    Wu, Yi-feng
    Huang, Chun-hou
    IN VIVO, 2023, 37 (03): : 1358 - 1364
  • [37] Management of non-small-cell lung cancer in the older adult
    VanderWalde, Ari
    Pal, Sumanta Kumar
    Reckamp, Karen L.
    MATURITAS, 2011, 68 (04) : 311 - 321
  • [38] Treatment of non-small-cell lung cancer in older persons
    Basche, M
    Kelly, K
    ONCOLOGY-NEW YORK, 2003, 17 (01): : 31 - 39
  • [39] Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy
    Noda-Narita, Shoko
    Naito, Tomoyuki
    Udagawa, Hibiki
    Goto, Koichi
    Miyawaki, Taichi
    Mamesaya, Nobuaki
    Nakashima, Kazuhisa
    Kenmotsu, Hirotsugu
    Shimokawaji, Tadasuke
    Kato, Terufumi
    Hakozaki, Taiki
    Okuma, Yusuke
    Nakamura, Masaki
    Nakayama, Yuko
    Watanabe, Hirokazu
    Kusumoto, Masahiko
    Ohe, Yuichiro
    Horinouchi, Hidehito
    CANCER SCIENCE, 2023, 114 (02) : 630 - 639
  • [40] Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung Cancer
    Ebadi, Maryam
    Ladbury, Colton
    Liu, Jason
    Rock, Adam
    Onyshchenko, Mykola
    Villaflor, Victoria
    Villalona-Calero, Miguel
    Salgia, Ravi
    Massarelli, Erminia
    Lee, Percy
    Williams, Terence
    Amini, Arya
    CLINICAL LUNG CANCER, 2023, 24 (07) : 651 - 659
12345